United States · Series B startup

Who invested in AutekBio

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$2.1Mraised across 2 rounds since 2007, from 2 sources

$1.1MSeries A$1.0MSeries B
Latest round
Series B, $1.0MOct 2007
Biggest round
$1.1MSeries A · Aug 2007
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2008
$1.1MSeries A$1.0MSeries B
First round
Series A, $1.1M
Aug 2007
Biggest round
$1.1M
Series A · Aug 2007
Between rounds
2 months
from the last two

The rounds

  1. Oct 2007
    Series B$1.0M1 new1 returning

    Reported by zero2ipo.com.cn

  2. Aug 2007
    Series A$1.1M1 new

    Reported by deals.venturebeat.com

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2007Series B2007Acorn CampusPrime Ventures

Everyone who backed them

Acorn CampusGrowth equity2rounds
Prime VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about AutekBio

Who invested in AutekBio?

AutekBio's investors include Acorn Campus and Prime Ventures.

How much has AutekBio raised?

AutekBio has raised $2.1M across 2 rounds since 2007.

When did AutekBio last raise?

AutekBio's most recent round was a Series B of $1.0M in Oct 2007.

What was AutekBio's biggest round?

AutekBio's largest round on record is $1.1M (Series A), in Aug 2007.

Who backed AutekBio first?

AutekBio's first round on record, in Aug 2007, was backed by Acorn Campus.

What stage is AutekBio at?

AutekBio's latest named round is a Series B, in Oct 2007.

Where is AutekBio based?

AutekBio is based in the United States.

Companies like AutekBio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.